76.43
전일 마감가:
$77.57
열려 있는:
$77.64
하루 거래량:
2.28M
Relative Volume:
0.57
시가총액:
$44.85B
수익:
$5.69B
순이익/손실:
$1.41B
주가수익비율:
11.00
EPS:
6.95
순현금흐름:
$577.90M
1주 성능:
-4.79%
1개월 성능:
-2.42%
6개월 성능:
+10.21%
1년 성능:
+11.45%
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
EW
Edwards Lifesciences Corp
|
76.39 | 45.54B | 5.69B | 1.41B | 577.90M | 6.95 |
![]()
ABT
Abbott Laboratories
|
131.54 | 232.75B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
100.29 | 152.19B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
377.61 | 146.55B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
93.57 | 120.61B | 34.20B | 4.69B | 5.30B | 3.63 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
2024-05-30 | 개시 | Goldman | Buy |
2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
2023-07-19 | 개시 | Robert W. Baird | Outperform |
2023-05-30 | 재개 | Morgan Stanley | Overweight |
2023-03-29 | 개시 | UBS | Neutral |
2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2022-10-26 | 개시 | Mizuho | Buy |
2022-10-18 | 개시 | Barclays | Overweight |
2022-10-12 | 개시 | Jefferies | Buy |
2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2022-04-13 | 개시 | Truist | Buy |
2022-04-06 | 개시 | Wolfe Research | Outperform |
2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2022-03-02 | 재개 | BofA Securities | Neutral |
2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
2022-01-27 | 재확인 | Citigroup | Buy |
2022-01-27 | 재확인 | Evercore ISI | Outperform |
2022-01-27 | 재확인 | Raymond James | Outperform |
2022-01-27 | 재확인 | Stifel | Buy |
2022-01-27 | 재확인 | UBS | Neutral |
2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2021-07-30 | 재확인 | Canaccord Genuity | Buy |
2021-07-30 | 재확인 | Deutsche Bank | Hold |
2021-07-30 | 재확인 | Jefferies | Buy |
2021-07-30 | 재확인 | Morgan Stanley | Overweight |
2021-07-30 | 재확인 | Oppenheimer | Outperform |
2021-07-30 | 재확인 | Stifel | Buy |
2021-07-30 | 재확인 | UBS | Neutral |
2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
2021-05-25 | 개시 | Barclays | Overweight |
2021-04-15 | 개시 | Atlantic Equities | Neutral |
2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
2020-12-11 | 재확인 | Canaccord Genuity | Buy |
2020-09-11 | 개시 | Wolfe Research | Underperform |
2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2020-03-05 | 개시 | Citigroup | Buy |
2020-02-13 | 개시 | Goldman | Neutral |
2020-02-06 | 재개 | BTIG Research | Neutral |
2020-01-10 | 개시 | Oppenheimer | Outperform |
2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2019-10-24 | 재확인 | Canaccord Genuity | Buy |
2019-09-23 | 개시 | Piper Jaffray | Overweight |
2019-07-24 | 재확인 | BofA/Merrill | Buy |
2019-03-18 | 재확인 | Canaccord Genuity | Buy |
2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-01-03 | 개시 | Deutsche Bank | Hold |
2018-11-28 | 개시 | UBS | Neutral |
2018-10-16 | 개시 | Barclays | Underweight |
2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Downgrade Watch: Whats the outlook for Edwards Lifesciences Corporations sectorFed Meeting & Short-Term Swing Trade Alerts - خودرو بانک
Jacobs & Co. CA Sells 7,261 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
24,437 Shares in Edwards Lifesciences Corporation $EW Purchased by AG2R LA Mondiale Gestion D Actifs - MarketBeat
Voya Investment Management LLC Lowers Position in Edwards Lifesciences Corporation $EW - MarketBeat
14,705 Shares in Edwards Lifesciences Corporation $EW Bought by Voleon Capital Management LP - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Swedbank AB - MarketBeat
Caxton Associates LLP Invests $370,000 in Edwards Lifesciences Corporation $EW - MarketBeat
Strs Ohio Makes New $9.49 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Glenview Trust co Trims Position in Edwards Lifesciences Corporation $EW - MarketBeat
Howe & Rusling Inc. Purchases 4,351 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Militia Capital Partners LP - MarketBeat
15,468 Shares in Edwards Lifesciences Corporation $EW Acquired by Everstar Asset Management LLC - MarketBeat
NewEdge Advisors LLC Lowers Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Vancity Investment Management Ltd Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Hancock Whitney Corp Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Alliancebernstein L.P. Reduces Position in Edwards Lifesciences Corporation $EW - MarketBeat
MBB Public Markets I LLC Buys New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Focus Partners Advisor Solutions LLC - MarketBeat
Teza Capital Management LLC Sells 71,252 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Polar Asset Management Partners Inc. Has $7.43 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Woodline Partners LP - MarketBeat
AQR Capital Management LLC Buys 709,648 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Holdings Lowered by Jacobs Levy Equity Management Inc. - MarketBeat
Amundi Has $213.04 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Picard Announces Appointment of Two New Members to its Board of Directors - GlobeNewswire Inc.
Quarry LP Sells 6,178 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS) - Insider Monkey
Adage Capital Partners GP L.L.C. Lowers Position in Edwards Lifesciences Corporation $EW - MarketBeat
Graham Capital Management L.P. Makes New $1.08 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Trexquant Investment LP Invests $2.47 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Edmond DE Rothschild Holding S.A. Has $47.94 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Royal Bank of Canada - MarketBeat
Is This the Dip to Buy in Edwards Lifesciences Corporation2025 Earnings Impact & Community Trade Idea Sharing - beatles.ru
Parkman Healthcare Partners LLC Acquires 55,605 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences Corporation in a bullish channel2025 Market WrapUp & Safe Entry Zone Identification - beatles.ru
Edwards Lifesciences Corporation $EW Shares Bought by MAI Capital Management - MarketBeat
OMERS ADMINISTRATION Corp Has $1.64 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Position Cut by Armistice Capital LLC - MarketBeat
Edwards acquires Vectorious for $497M - BioWorld MedTech
Edwards Lifesciences’ TAVR growth continues as global demand rises - Yahoo Finance
Edwards Lifesciences Corporation stock trendline breakdown2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant - MassDevice
Edwards Lifesciences Acquires Israeli Medtech Firm Vectorious Medical for $497m Valuation - AInvest
Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by Wall Street Zen - MarketBeat
What Fibonacci levels say about Edwards Lifesciences Corporation reboundWeekly Profit Report & Long-Term Growth Portfolio Plans - Newser
Is Edwards Lifesciences Corporation meeting your algorithmic filter criteriaMarket Sentiment Review & Real-Time Volume Trigger Notifications - Newser
Is it time to cut losses on Edwards Lifesciences CorporationMarket Growth Report & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-03 02:50:15 - Newser
Using AI based signals to follow Edwards Lifesciences CorporationJuly 2025 Highlights & Fast Moving Market Watchlists - Newser
How to read the order book for Edwards Lifesciences CorporationJuly 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - Newser
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):